ORCID
Masahiko Takaya
https://orcid.org/0000-0003-1450-4173
1. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263-269.
2. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement.2011;7(3):270-279.
3. Lal C, Siddiqi N, Kumbhare S, Strange C. Impact of medications on cognitive function in obstructive sleep apnea syndrome. Sleep Breath. 2015;19(3):939-945.
4. Mayo SJ, Lustberg M, H MD, et al. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer. 2020.
5. Hosokawa C, Ishii K, Hyodo T, et al. Investigation of (11)C-PiB equivocal PET findings. Ann Nucl Med. 2015;29(2):164-169.
6. Lockhart SN, Baker SL, Okamura N, et al. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351. PLoS One.2016;11(6):e0158460.
7. van der Willik KD, Schagen SB, Ikram MA. Cancer and dementia: Two sides of the same coin? Eur J Clin Invest. 2018;48(11):e13019.
8. Attier-Zmudka J, Serot JM, Valluy J, et al. Sleep Apnea Syndrome in an Elderly Population Admitted to a Geriatric Unit: Prevalence and Effect on Cognitive Function. Front Aging Neurosci. 2019;11:361.